Royal DSM NV (DSM) - Financial and Strategic SWOT Analysis Review

  • ID: 1648305
  • SWOT Analysis
  • 71 pages
  • GlobalData
  • DSM Company
1 of 5

FEATURED COMPANIES

  • Akzo Nobel NV
  • BASF SE
  • Clariant International AG
  • Novozymes AS
  • Solvay SA
  • MORE
Royal DSM NV (DSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Royal DSM NV (DSM) is a science-based company with focus on materials, health and nutrition. It produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resins solutions. DSM develops materials for medical devices and clean energy from crop residues and bio-chemicals. The company serves customers in animal nutrition and health, packaging and graphic arts, building and construction, pharma solutions, electrical and electronics, automotive, medical, personal care, energy, food, furniture, life protection, beverages and dietary supplements, marine, paint and coatings, manufacturing and equipment, sports, leisure and consumer goods, and textiles and clothing sectors. The company has operations across Eastern Europe, Latin America, North America, Asia, and other regions. DSM is headquartered in Heerlen, the Netherlands.

Royal DSM NV Key Recent Developments

Mar 20, 2018: AkzoNobel, DSM, Google and Philips receive first power from new Dutch wind farm Bouwdokken
Feb 15, 2018: DSM Reports 2017 Results
Dec 11, 2017: Syngenta's Chief Financial Officer Mark Patrick Joins Peers In Leading Way To Support Adoption Of Climate-Related Financial Disclosures
Dec 11, 2017: DSM Announces Akulon and Novamid Polyamide 6 Price Increase
Nov 02, 2017: DSM Reports Results First Nine Months 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Akzo Nobel NV
  • BASF SE
  • Clariant International AG
  • Novozymes AS
  • Solvay SA
  • MORE
Section 1 - About the Company
  • Royal DSM NV - Key Facts
  • Royal DSM NV - Key Employees
  • Royal DSM NV - Key Employee Biographies
  • Royal DSM NV - Major Products and Services
  • Royal DSM NV - History
  • Royal DSM NV - Company Statement
  • Royal DSM NV - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Royal DSM NV - Business Description
  • Business Segment: Innovation Center
  • Overview
  • Performance
  • Business Segment: Materials
  • Overview
  • Performance
  • Business Segment: Nutrition
  • Overview
  • Performance
  • Geographical Segment: China
  • Performance
  • Geographical Segment: Eastern Europe
  • Performance
  • Geographical Segment: India
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: Latin America
  • Performance
  • Geographical Segment: North America
  • Performance
  • Geographical Segment: Rest of Asia
  • Performance
  • Geographical Segment: Rest of the World
  • Performance
  • Geographical Segment: Rest of Western Europe
  • Performance
  • Geographical Segment: The Netherlands
  • Performance
  • R&D Overview
  • Royal DSM NV - Corporate Strategy
  • Royal DSM NV - SWOT Analysis
  • SWOT Analysis - Overview
  • Royal DSM NV - Strengths
  • Royal DSM NV - Weaknesses
  • Royal DSM NV - Opportunities
  • Royal DSM NV - Threats
  • Royal DSM NV - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences, Power Financial Deals and Alliances
  • Royal DSM NV, Petrochemicals, Deals By Year, 2012 to YTD 2018
  • Royal DSM NV, Petrochemicals, Deals By Type, 2012 to YTD 2018
  • Royal DSM NV, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Feb 15, 2018: DSM Reports 2017 Results
  • Dec 11, 2017: Syngenta's Chief Financial Officer Mark Patrick Joins Peers In Leading Way To Support Adoption Of Climate-Related Financial Disclosures
  • Dec 11, 2017: DSM Announces Akulon and Novamid Polyamide 6 Price Increase
  • Nov 02, 2017: DSM Reports Results First Nine Months 2017
  • Aug 22, 2017: DSM Names Olivier Janin To Head Sales & Marketing DSM Dyneema
  • Jun 27, 2017: SunRISE TechBridge Challenge II winners announced by DSM, Fraunhofer TechBridge and Greentown Labs
  • Jun 14, 2017: Alpiq and the fine chemicals manufacturer DSM make secondary balancing power available to Swissgrid
  • May 02, 2017: DSM Q1 2017 Results
  • Apr 03, 2017: Royal DSM Opens New Biotechnology Center in Delft, the Netherlands
  • Mar 02, 2017: DSM Again Helps Startups Accelerate Innovations in Solar Materials Through Unique SunRISE Competition and Acceleration Program
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Royal DSM NV, Key Facts
  • Royal DSM NV, Key Employees
  • Royal DSM NV, Key Employee Biographies
  • Royal DSM NV, Major Products and Services
  • Royal DSM NV, History
  • Royal DSM NV, Other Locations
  • Royal DSM NV, Subsidiaries
  • Royal DSM NV, Joint Venture
  • Royal DSM NV, Key Competitors
  • Royal DSM NV, Ratios based on current share price
  • Royal DSM NV, Annual Ratios
  • Royal DSM NV, Annual Ratios
  • Royal DSM NV, Annual Ratios
  • Royal DSM NV, Interim Ratios
  • Royal DSM NV, Petrochemicals, Deals By Year, 2012 to YTD 2018
  • Royal DSM NV, Petrochemicals, Deals By Type, 2012 to YTD 2018
  • Royal DSM NV, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Royal DSM NV, Performance Chart (2013 - 2017)
  • Royal DSM NV, Ratio Charts
  • Royal DSM NV, Petrochemicals, Deals By Year, 2012 to YTD 2018
  • Royal DSM NV, Petrochemicals, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Solvay SA
  • Novozymes AS
  • Clariant International AG
  • BASF SE
  • Akzo Nobel NV
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll